Why Doctors Don’t Believe Chronic Lyme Disease
“My doctor told me it’s all in my head.”
If you have been told your persistent symptoms are imaginary, exaggerated, or unrelated to Lyme disease—you are not alone.
The dismissal you are experiencing is real. And it happens more often than it should.
Not all physicians dismiss persistent Lyme symptoms. Many are working within training, guidelines, and system constraints that do not fully reflect the complexity of this illness.
This page is not about blame—it’s about understanding why this gap exists, so patients can navigate care more effectively.
Many patients are told that Lyme disease doesn’t last that long, that further treatment is unnecessary, or that they should simply accept a diagnosis of post-treatment Lyme disease syndrome (PTLDS) and move on.
This creates confusion, frustration, and in many cases, medical abandonment.
Understanding why doctors dismiss chronic Lyme disease involves examining medical training, institutional guidelines, scientific controversy, economic pressures, and deeply embedded assumptions about what Lyme disease “should” look like. These forces do not excuse the harm they cause—but they can help patients navigate a medical system that too often fails them.
Medical Training Shapes What Doctors Believe Is Possible
Physicians are taught that Lyme disease is easy to diagnose (look for the bull’s-eye rash), easy to treat (2–4 weeks of antibiotics), and easy to cure (symptoms resolve completely).
This framework is presented as settled science in most medical schools and residency programs. It is reinforced through textbooks, board exams, and continuing medical education.
The problem is that this teaching does not match clinical reality.
Many patients never develop a rash. Many are not diagnosed early. And many do not recover fully after standard treatment.
When a physician trained in the “textbook” model encounters a patient whose illness does not fit that pattern, the instinct is often to question the diagnosis—not the model.
I was trained in this same system. Early in my career, I believed what I had been taught. It was only after seeing patient after patient who defied the textbook that I began to question whether the framework itself was incomplete.
Institutional Guidelines Create Professional Risk
Medical guidelines are intended to standardize care and ensure quality. But in Lyme disease, they can create constraints.
Guidelines from organizations such as the Infectious Diseases Society of America (IDSA) assert that Lyme disease is rarely chronic and that extended antibiotic therapy is not supported by evidence.
Physicians who deviate from these guidelines may face scrutiny from medical boards, insurance denials, criticism from colleagues, or legal risk.
This creates a chilling effect. Even physicians who recognize gaps in the guidelines may feel unable to act on that knowledge.
The Nomenclature Debate: PTLDS vs. Chronic Lyme
Terminology shapes care.
PTLDS assumes infection has been eradicated and symptoms are not due to ongoing infection.
Chronic Lyme disease allows for persistent infection, immune dysregulation, or untreated co-infections.
This distinction determines whether symptoms are investigated—or dismissed.
Labels should not be used to shut down clinical inquiry.
Economic and System Pressures
Modern medicine prioritizes efficiency.
Short visits, insurance constraints, and billing structures limit the time available for complex cases.
Lyme disease often presents as a multi-system illness that does not fit neatly into this model.
When the system does not support complexity, dismissal can become the default.
Scientific Uncertainty Is Treated as Certainty
There is ongoing debate about persistent infection, immune dysregulation, and co-infections.
But patients are often told these issues are settled—and that their symptoms cannot be explained by Lyme disease.
Uncertainty in science does not justify certainty in dismissal.
The Impact: Medical Abandonment
Patients describe:
- Loss of trust in the medical system
- Delays in diagnosis
- Psychological harm from dismissal
- Financial burden seeking care elsewhere
- Isolation and frustration
This is medical abandonment—the failure to provide care when illness does not fit a recognized framework.
Learn more in our ethics framework.
What Patients Can Do
- Seek Lyme-literate physicians (ILADS referrals)
- Document symptoms carefully
- Advocate for further evaluation
- Do not internalize dismissal
Your symptoms are real—even if they are not understood.
What Medicine Owes Patients
- Acknowledge uncertainty
- Investigate persistent symptoms
- Provide continuity of care
- Respect patient autonomy
- Update guidelines as evidence evolves
Progress is happening—but slowly.
Clinical Takeaway
Chronic Lyme disease is dismissed not because patients are wrong, but because the medical system struggles to address complex, persistent illness.
You are not imagining your symptoms. You deserve care, investigation, and respect.
If you are still searching for answers, do not give up. Recovery is possible.
Frequently Asked Questions
Why do doctors dismiss chronic Lyme disease?
Due to medical training, guidelines, risk, time constraints, and scientific uncertainty.
What is the difference between PTLDS and chronic Lyme?
PTLDS assumes no infection; chronic Lyme allows for ongoing causes of symptoms.
Can I be dismissed even with positive tests?
Yes. Some physicians follow strict guidelines regardless of test results.
What should I do if I’m dismissed?
Seek a Lyme specialist, document symptoms, and advocate for yourself.
Is medical abandonment recognized?
Yes. It is increasingly viewed as a systemic ethical issue.
Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.
Symptoms • Testing • Coinfections • Recovery • Pediatric • Prevention
